Fears of COVID-19 and cancer recurrence related to work sustainability among male cancer survivors

Purpose: Male cancer survivors represent an important at-risk population for COVID-19. The COVID-19 pandemic requires a global response for this most vulnerable population. This study purpose was to explore whether fear of COVID-19 and fear of cancer recurrence are related to the likelihood of remaining at work following treatment in male cancer survivors.

Survivors and methods: A cross-sectional survey was used. Data were collected in China in May to June 2020. The Fear of COVID-19 Scale, Fear of Cancer Recurrence (FCR) Inventory-Short Form and work sustainability subscale of the Readiness for Return to Work Scale were completed by male cancer survivors.

Results: A total of 121 employed male cancer survivors participated in this study. Fear of COVID-19 and fear of cancer recurrence were both negatively correlated with work sustainability (β = -0.11, and β = -0.19, respectively). Significant interaction effects between fear of COVID-19 and fear of cancer recurrence were observed (β = 0.46, P < 0.01). Advanced disease stage, undergoing radiation therapy and having recently completed cancer treatment were all factors related to lower work sustainability scores (β = -0.28, β = -0.15, and β = -0.17, respectively). The overall path model yielded a good fit: χ²/df = 1.12 (P = 0.24), RMSEA = 0.07, TLI = 0.98, CFI = 0.99, IFI = 0.92, and NFI = 0.96.

Conclusion: Fear of COVID-19 is a mediator between fear of cancer recurrence and work sustainability among Chinese male cancer survivors. The findings also indicated that male cancer survivors with higher FCR levels reported less confidence in their ability to remain at work. This information can assist in the development of new interventions and educational programs for cancer survivors, healthcare providers and employers, to improve employees' ability to remain at work.

Fear of COVID-19; Fear of cancer recurrence; Work retention; Male cancer survivors

[1] World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-209. 2020. Available at: https://www.who. int/docs/default-source/coronaviruse/situation-reports/20200816-covid-19-sitrep-209.pdf?sfvrsn= 5dde1ca2_2 (Accessed: 1 September 2020).

[2] Johns Hopkins University & Medicine. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2020. Available at: https://coronavirus.jhu. edu/map.html (Accessed: 31 December 2020).

[3] Printz C. When a global pandemic complicates cancer care. Cancer. 2020; 126: 3171-3173.

[4] Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Global Oncology. 2020; 6: 557-559.

[5] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians. 2020; 70: 7-30.

[6] Wild CP, Weiderpass E, Stewart BW. World cancer report: cancer research for cancer prevention. Lyon, France: International Agency for Research on Cancer. 2020.

[7] Aschebrook-Kilfoy B, James B, Nagar S, Kaplan S, Seng V, Ahsan H, et al. Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American thyroid cancer survivorship study. Thyroid. 2015; 25:1313-1321.

[8] Diamond-Rossi SA, Jonklaas J, Jensen RE, Kuo C, Stearns S, Esposito G, et al. Looking under the hood of “the Cadillac of cancers:” radioactive iodine-related craniofacial side effects among patients with thyroid cancer. Journal of Cancer Survivorship. 2020; 14: 847-857.

[9] Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. The increasing value of eHealth in the delivery of patient-centred cancer care. The Lancet Oncology. 2020; 21: e240-e251.

[10] Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. Journal of Cancer Survivorship. 2013; 7: 300-322.

[11] Wang H, Zhang L. Risk of COVID-19 for survivors with cancer. The Lancet Oncology. 2020; 21: e181.

[12] Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. International Journal of Mental Health and Addiction. 2020; 1-9.

[13] Peng L, Huang W, Zhang W, Xu Y, Lu F, Zhong L, et al. Psychometric properties of the short form of the Fear of Cancer Recurrence Inventory (FCRI) in Chinese breast cancer survivors. Front Psychiatry. 2019; 10: 537.

[14] Park J, Roberts MR, Esmail S, Rayani F, Norris CM, Gross DP. Validation of the readiness for return-to-work scale in outpatient occupational rehabilitation in Canada. Journal of Occupational Reha-bilitation. 2018; 28: 332-345.

[15] Xu YW, Luo XY, Lu XW, Lam SC. Reliability and validity of the lam assessment of employment readiness for injured workers. Chinese Journal of Rehabilitation Theory and Practice. 2014; 20: 592-596.

[16] Kline RB. Principles and practice of structural equation modeling. 2nd ed. New York: Guilford Press. 2005.

[17] Hedman C, Strang P, Djärv T, Widberg I, Lundgren CI. Anxiety and fear of recurrence despite a good prognosis: an interview study with differentiated thyroid cancer patients. Thyroid. 2017; 27: 1417-1423.

[18] Papaleontiou M, Reyes-Gastelum D, Gay BL, Ward KC, Hamilton AS, Hawley ST, et al. Worry in thyroid cancer survivors with a favorable prognosis. Thyroid. 2019; 29: 1080-1088.

[19] Nott D. The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises. The Lancet. 2020; 395: 1532-1533.

[20] Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. Journal of Cancer Survivorship. 2010; 4: 415-437.

[21] American Society of Clinical Oncology. A Guide to Cancer Care Delivery During the COVID-19 Pandemic. 2020. Available at: https://www.asco.org/asco-coronavirus-information (Accessed: 30 June 2020).

[22] Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. 2020; 21: 335-337.

[23] Shaw WS, Main CJ, Findley PA, Collie A, Kristman VL, Gross DP. Opening the workplace after COVID-19: what lessons can be learned from return-to-work research? Journal of Occupational Rehabilitation. 2020; 30: 299-302.

[24] Guven DC, Sahin TK, Aktepe OH, Yildirim HC, Aksoy S, Kilickap S. Perspectives, knowledge, and fears of cancer patients about COVID-19. Frontiers in Oncology. 2020; 10: 1553.

[25] Ekenga CC, Kwon E, Kim B, Park S. Long-term employment outcomes among female cancer survivors. International Journal of Environmental Research and Public Health. 2020; 17: 2751.